Herein, we also report that loss of markers of LGR5+ stem cells is associated with a compensatory enrichment of the fetal-like intestinal stem cell signature in HG CRC cell lines and primary tumours, identifying a further context in which this reprogramming occurs. The gene discussed is LGR5; the disease is neoplasm.